Characterization of Unilateral Polycystic Ovary Compared with Polycystic Ovary Syndrome
Liangqing Yao,Kuang Jian-quan,Feng Yan,Dongzi Yang,Lin Li,Congjian Xu
DOI: https://doi.org/10.1016/j.fertnstert.2005.08.054
IF: 6.7
2006-01-01
Fertility and Sterility
Abstract:Twelve patients with unilateral polycystic ovarian morphology demonstrated milder degrees of ovarian and other endocrine dysfunction than polycystic ovary syndrome patients and had fewer incidences of hyperprolactinemia and hyperandrogenism. Twelve patients with unilateral polycystic ovarian morphology demonstrated milder degrees of ovarian and other endocrine dysfunction than polycystic ovary syndrome patients and had fewer incidences of hyperprolactinemia and hyperandrogenism. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 4% to 8% of reproductive-aged women (1Azziz R. Woods K.S. Reyna R. Key T.J. Knochenhauer E.S. Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population.J Clin Endocrinol Metab. 2004; 89: 2745-2749Crossref PubMed Scopus (1940) Google Scholar). This syndrome is not a well-defined entity and shows great variation and heterogeneity of clinical expression. Characteristically, polycystic ovaries when seen macroscopically are enlarged, and the diagnosis is based on ultrasonographic demonstration (2McKenna T.J. Cummingham S.K. Adrenal androgen production in polycystic ovary syndrome.Eur J Endocrinol. 1995; 133: 383-389Crossref PubMed Scopus (22) Google Scholar, 3Ardaens Y. Robert Y. Lemaitre L. Fossati P. Dewailly D. Polycystic ovarian disease contribution of vaginal endosonography and reassessment of ultrasonic diagnosis.Fertil Steril. 1991; 55: 1062-1068Abstract Full Text PDF PubMed Scopus (94) Google Scholar). However, this sign is not uniformly seen in PCOS (4Gordon C.M. Menstrual disorders in adolescents excess androgens and the polycystic ovary syndrome.Pediatr Clin N Am. 1999; 46: 519-543Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar); studies have found a prevalence of polycystic ovaries in normally cycling women (5Frandks S. Polycystic ovary syndrome.N Engl J Med. 1995; 333: 853-861Crossref PubMed Scopus (1761) Google Scholar). Usually, PCOS usually represents a spectrum of disorders rather than a disease, and the clinical features presented by polycystic ovaries are generally believed to be reversible. Bilaterally enlarged ovaries are characteristic of PCOS (6Polson D.W. Adams J. Steer P.J. Franks S. Unilateral polycystic ovary Case report.Br J Obstet Gynecol. 1986; 93: 1100-1104Crossref PubMed Scopus (15) Google Scholar), but unilateral polycystic ovarian morphology (PCO), a special type found in a unilateral ovary, has come to our attention in clinical practice (Fig. 1A, B). We have observed it in both classic PCOS patients and non-PCOS patients. Although unilateral PCO has been recognized since 1964 (6Polson D.W. Adams J. Steer P.J. Franks S. Unilateral polycystic ovary Case report.Br J Obstet Gynecol. 1986; 93: 1100-1104Crossref PubMed Scopus (15) Google Scholar, 7Dignam W.J. Pion R.J. Lamb E.J. Simmer H.H. Plasma androgens in women.Acta Endocrinol. 1964; 45: 254-271PubMed Google Scholar, 8Vejlsted H. Alvrechtsen R. Biochemical and clinical effect of ovarian wedge resection in the polycystic ovary syndrome.Obstet Gynecol. 1976; 47: 575-580PubMed Google Scholar), its etiology, clinical features, and relationship with PCOS remain unclear. Our study explored the characterization and relationship unilateral PCO with PCOS. Twelve unilateral PCO patients who underwent laparoscopy were studied from August 2002 to present. Indications for surgery included seven cases of infertility, one case of uterine myoma, one case of longitudinal vaginal septum, and three cases of pelvic inflammatory disease. The study also included eight cases of typical PCOS (PCOS patients with bilateral PCO) who underwent laparoscopy for infertility. A control group of 15 patients with infertility but without endocrine disorders were enrolled, including 13 cases of tubal obstruction, one case of endometriosis, and one case of uterine myoma. All of the PCO cases were confirmed by ultrasound and fit the criteria described by Balen (9Balen A. Ovulation induction for polycystic ovary syndrome.Hum Fertil (Camb). 2003; 3: 106-111Crossref Scopus (13) Google Scholar, 10Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril. 2004; 81: 19-25Scopus (0) Google Scholar). Diagnostic criteria of PCOS were referred as Rotterdam Consensus (10Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril. 2004; 81: 19-25Scopus (0) Google Scholar). It should be emphasized that hyperprolactinemia was adopted as an exclusion for related diseases in this study (10Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril. 2004; 81: 19-25Scopus (0) Google Scholar). The protocol was approved by the institutional review committee of both hospitals, and written informed consent was obtained from each patient before entry into the study. Clinical data included general materials, history, signs, and pelvic examination. All patients were examined using gynecologic ultrasonography. Measurements of serum hormone levels included estradiol (E2), luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), prolactin (PRL) and insulin by chemiluminescence autography (Bayer Corp., Tarrytown, NY). Dehydroepiandrosterone sulfate (DHEAS) and androstenedione (A2) were measured using enzyme-linked immunoabsorbent assay (ELISA) (Diagnostic Systems Laboratories, Inc., Weber, TX). Biopsy samples of bilateral ovarian tissues were also obtained. Follicular fluid was collected from follicles of 2 to 8 mm in size under anatomic microscope. We obtained 16 samples of bilateral ovaries from the typical PCOS group, 20 samples from the unilateral PCO group (12 from PCO and eight from normal sides), and 19 samples from the control group. The methods for measuring levels of LH, T, insulin, A2, and DHEAS in follicular fluid were the same as for serum. Ultrastructures of ovarian stroma cells were observed by transmission electron microscope (H-600 transmission electron microscope; Hitachi, Tokyo, Japan). All statistical analyses were performed with SPSS 11.0 software (SPSS Inc, Chicago, IL). Categorical data were analyzed by Pearson chi-square test. Continuous variables were analyzed using t-tests or one-way analysis of variance (ANOVA). Two-tailed P values of <.05 were considered statistically significant. Among the 12 unilateral PCO patients, seven patients showed right PCO (58.33%); the rest showed left PCO (41.67%). The study also showed seven cases of primary or secondary infertility (58.33%). Among them, three patients had abnormal menstruation (oligomenorrhea or/and hypomenorrhea) (25%), four patients showed obesity (33.33%), and one patient had hirsutism (8.33%). The incidences of abnormal menstruation and infertility were statistically significantly lower than found in the typical PCOS group (both P<.05). Three patients with unilateral PCO were confirmed by the diagnostic standards of PCOS. The serum LH level in the PCOS group (14.81 ± 5.78 IU/L) was statistically significantly higher than in the unilateral PCO group (6.93 ± 3.43 IU/L, P=.00) and the control group (3.47 ± 2.19 IU/L, P=.00). The insulin level in the PCOS group (10.69 ± 6.21 mU/L) was also statistically significantly higher than the level in the control group (5.55 ± 3.46 mU/L, P=.023); no difference was found versus the unilateral PCO group (6.75 ± 3.05 mU/L, P=.161). The T levels in the PCOS group (9.35 ± 6.69 nmol/L) and unilateral PCO group (4.48 ± 1.04 nmol/L) were both higher than in the control group (1.29 ± 0.14 nmol/L, P=.036 and P=.042, respectively). The PRL level was higher in the unilateral PCO group (633.89 ± 44.26 μIU/mL) than in the PCOS group (189.78 ± 32.75 μIU/mL, P=.018) or the control group (224.08 ± 29.48 μIU/mL, P=.027). The T and insulin levels of follicular fluid from the typical PCOS group (93.24 ± 34.63 nmol/L, 7.62 ± 3.07 mU/L) and the PCO side of unilateral PCO (70.36 ± 24.11 nmol/L, 6.56 ± 3.47 mU/L) were statistically significantly higher than those found in the normal group (35.32 ± 5.56 nmol/L, 1.44 ± 0.16 mU/L, all P<.01) or the normal side of unilateral PCO (46.45 ± 10.68 nmol/L, 2.22 ± 1.07 mU/L, all P<.01). The LH levels of the follicular fluid from the typical PCOS group (10.43 ± 3.67 IU/L) were noticeably higher than those of the PCO side of unilateral PCO (4.90 ± 1.22 IU/L, P=.039), normal side of unilateral PCO (4.60 ± 2.31 IU/L, P=.033), or normal control group (3.19 ± 1.87 IU/L, P=.021). Ultrastructures of ovarian stroma cells in unilateral PCO showed increased cytoplasm, enlarged rough endoplasmic reticulum (RER), smooth endoplasmic reticulum (SER), occasionally degranulated RER on the PCO side, and increased and enlarged SER on the normal side. These changes are shown in Figure 1C and D. Additionally, bilateral ovarian stroma cells in the typical PCOS group had increased cytoplasm, enlarged RER and SER with degranulation of some RER, dilated mitochondria or even broken mitochondrial cristae, occasional vacuolar degeneration, and fatty drops in some cytoplasm. Polycystic ovary syndrome describes a group of women with symptoms of obesity, hirsutism, oligomenorrhea, and characteristic bilateral ovarian enlargement (6Polson D.W. Adams J. Steer P.J. Franks S. Unilateral polycystic ovary Case report.Br J Obstet Gynecol. 1986; 93: 1100-1104Crossref PubMed Scopus (15) Google Scholar). Unilateral PCO has been recognized since 1964 (7Dignam W.J. Pion R.J. Lamb E.J. Simmer H.H. Plasma androgens in women.Acta Endocrinol. 1964; 45: 254-271PubMed Google Scholar, 8Vejlsted H. Alvrechtsen R. Biochemical and clinical effect of ovarian wedge resection in the polycystic ovary syndrome.Obstet Gynecol. 1976; 47: 575-580PubMed Google Scholar). In the two cases of single PCO that had been observed among over 100 women with polycystic ovaries, the presentation was different. One woman had none of the stigmata associated with PCOS. In contrast, the other had secondary amenorrhea. The report indicated that the etiology of the disorder remained unknown (6Polson D.W. Adams J. Steer P.J. Franks S. Unilateral polycystic ovary Case report.Br J Obstet Gynecol. 1986; 93: 1100-1104Crossref PubMed Scopus (15) Google Scholar). Our study demonstrated that patients with unilateral PCO have diverse characteristics and may display many symptoms of typical PCOS, such as infertility, abnormal menstruation, obesity, or hirsutism. A few patients without characteristic manifestations were diagnosed by ultrasonography while being treated for other diseases. The incidence of infertility and abnormal menstruation was lower in unilateral PCO group than in the typical PCOS group. It has been demonstrated that damage to ovarian reproductive and endocrine functions in unilateral PCO is milder than in PCOS, but unilateral PCO can be more difficult to diagnose. Hyperandrogenism is responsible for the physical characteristics of PCOS (11Azziz R. Androgen excess is the key element in polycystic ovary syndrome.Fertil Steril. 2003; 80: 252-254Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar). The prevalence of hyperprolactinemia in women with polycystic ovaries is about 5% to 30% (12Cetinkaya E. Ocal G. Berberoglu M. Adiyaman P. The risk of functional ovarian hyperandrogenism and polycystic ovary syndrome in patients with hyperandrogenism.J Pediatr Endocrinol Metab. 2003; 16: 1011-1016Crossref PubMed Scopus (4) Google Scholar). Conversely, polycystic ovaries have been noted among patients with proved prolactinomas (13Futterweit W. Pituitary tumors and polycystic ovarian disease.Obstet Gynecol. 1983; 62: 74s-79sPubMed Google Scholar). The sera T and PRL levels were higher in unilateral PCO than in normal women in our study. These findings suggested that isolated unilateral PCO might be associated with a lower incidence of hyperprolactinemia and hyperandrogenism. The role of hyperprolactinemia in typical PCOS could not be excluded because the criteria used in our study might have caused subject-selective bias of PCOS cases. Elevated T and insulin levels of follicular fluid were found in unilateral PCO, but not on the normal side. This suggests that the intra-ovarian factors, such as elevated insulin and T levels, may play an important role in the pathogenesis of unilateral PCO. Ibrahim and Aydin (14Ibrahim S. Aydin A. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.Obstet Gynecol Surv. 2000; 55: 321-328Crossref PubMed Scopus (53) Google Scholar) analyzed insulin resistance and hyperandrogenism in PCOS according to data published between 1996 and 2000; they concluded that hyperinsulinemia could aggravate hyperandrogenism and vice versa. Regardless of the triggering cause, the vicious circle had begun, and a similar effect may exist in isolated unilateral PCO. Surprisingly, sera insulin levels of unilateral polycystic ovaries did not increase accordingly. No elevated LH level was found in either follicular fluid or serum with unilateral PCO, which indicates further that local ovarian disturbances might play a key role in the pathogenesis of unilateral PCO. More in depth research is needed to elucidate the mechanism. The increased and enlarged SER on the normal side in unilateral PCO suggests that the stroma cells might be related to increased hormone synthesis. Enlarged RER and SER as well as dilated mitochondria on the unilateral PCO side indicate the active synthesis of protein and hormones. Those changes occurring in the stroma cells in PCOS are the decompensation signs of cell organs (15Rubin E. Farber J.L. Pathology. 3rd ed. Lippincott-Raven, Philadelphia1998Google Scholar, 16Singh K.B. Mahajan D.K. Ultrastructural basis for continued steroidogenesis in the rat polycystic ovary.J Reprod Med. 1990; 35: 2Google Scholar). From ultrastructural analysis of stroma cells in our study, we found that the morphologic changes of unilateral PCO occurred between normal ovaries and typical PCOS. Previous reports have showed that only a few cases of unilateral PCO meet the standard diagnostic criteria of PCOS (6Polson D.W. Adams J. Steer P.J. Franks S. Unilateral polycystic ovary Case report.Br J Obstet Gynecol. 1986; 93: 1100-1104Crossref PubMed Scopus (15) Google Scholar). Our results were consistent with those early findings; only three out of 12 unilateral PCO cases fit the criteria of classic PCOS. Therefore, our study suggests that the unilateral PCO could have specific characteristics that differ from PCOS. Further study with larger samples and long-term follow-up will be necessary to determine whether unilateral PCO could be a special type of transit of a normal ovary to PCOS.